top of page
Dr. Allal Boutajangout
Director, NYU Langone Health, USA
My Research
Therapy and immunotherapy of Alzheimer's disease and other neurodegenerative diseases such as prion disease, frontotemporal dementia, traumatic brain injury, chronic traumatic encephalopathy; monoclonal antibodies, transgenic mice,Diagnosis and Biomarkers
Summary
My current research focuses on Alzheimer’s disease and related disorders, with a particular interest in immunotherapy. I am currently in the process of testing the efficacy of generated antibodies in different neurodegenerative diseases, in addition to identifying novel blood biomarkers for the prediction and monitoring of disease progression- crucial for detection of early stage AD.
bottom of page